November 25, 2025 · Form 4 insider transaction
De Witte Jan sold 2,055 shares of ResMed Inc. at $255.00 per share, a transaction worth $524.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transaction was conducted under a Rule 10b5-1 plan adopted on August 18, 2025.